UC researchers open Phase 2 clinical trial to test new combination treatment for glioblastomas

A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors.

Evotec SE provides guidance update – Biotech Investments

Evotec SE / Key word(s): Change in Forecast Evotec SE provides guidance update 06-Aug-2024 / 21:04 CET/CEST Disclosure of an inside information acc. to Article

August 7, 2024

STAT+: ARCH Venture Partners is raising $3 billion for a life sciences fund

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund. The Chicago-based firm filed paperwork

February 3, 2024

Genentech adopts racial justice lens for new funding that goes beyond typical health equity grants

Genentech is starting a new kind of health equity fund looking through a racial justice lens that it hopes others in the industry will follow.

August 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.